Boehringer Ingelheim and Eli Lilly and Company Alliance to Feature 34 Presentations in Type 1 and Type 2 Diabetes at ... INGELHEIM, Germany and INDIANAPOLIS--(BUSINESS WIRE)--Ex US & UK Medical Media Only Boehringer Ingelheim and Eli Lilly and Company are pleased to announce that the companies’ diabetes alliance will have a strong scientific and clinical presence at the 73rd American Diabetes Association (ADA) Scientific Sessions® in Chicago, 21–25 June, with 34 posters, abstracts and an oral presentation ...
June 11, 2013 - Business Wire
Champions Oncology Study Results Highlighted in Presentation at ASCO HACKENSACK, N.J. -- Champions Oncology, Inc. (OTC:CSBR) is pleased to announce the oral presentation of a new paper, "Integrated Genomics and Avatar Mouse Models for Personalized Cancer Treatment", ...
June 5, 2013 - GlobeNewswire via Yahoo! Finance